This report shows information submitted by European Union Member States on the occurrence of zoonoses and food-borne outbreaks in 2005, analysed by the European Centre for Disease Prevention and Control and the European Food Safety Authority.
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
The authors assess the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011 (this period included a large outbreak in 2010).
On 3 July the Cuban Ministry of Health confirmed an outbreak of cholera in the south-western city of Manzanillo. It is the first time in almost 150 years that an outbreak of cholera is reported in the island.
With more than 32 000 cases, gonorrhoea was the second most commonly reported sexually transmitted infection (STI) in Europe in 2010. As data from the ECDC report Gonococcal antimicrobial susceptibility surveillance in Europe 2010 illustrates, gonococci have become more resistant to common agents for treatment and show reduced susceptibility to newer antibiotics. “This indicates the risk that gonorrhoea may become an untreatable disease in the near future”, stresses ECDC Director Marc Sprenger.
This expert meeting was part of the ECDC project on chlamydia control in Europe and aimed to provide EU Member States with evidence-based information that is needed for the development and evaluation of chlamydia control strategies and to monitor progress in chlamydia control in Europe.
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.